Shiga Toxin-Producing Escherichia coli Transmission via Fecal Microbiota Transplant.
Caroline ZellmerMohamad R A SaterMiriam H HuntleyMajdi OsmanScott W OlesenBharat RamakrishnaPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Fecal microbiota transplantation (FMT) is recommended therapy for multiply recurrent Clostridioides difficile infection. We report adverse events in 7 patients who received FMT from a stool donor who was colonized with Shiga toxin-producing Escherichia coli (STEC). No patients died of FMT-transmitted STEC. Improved screening can likely avoid future transmission.